- Home
- OUT vs RARE Comparison
OUT vs RARE Comparison
Compare OUT & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUT
- RARE
- Stock Information
- Founded
- OUT 2013
- RARE 2010
- Country
- OUT United States
- RARE United States
- Employees
- OUT N/A
- RARE N/A
- Industry
- OUT Real Estate Investment Trusts
- RARE Biotechnology: Pharmaceutical Preparations
- Sector
- OUT Real Estate
- RARE Health Care
- Exchange
- OUT Nasdaq
- RARE Nasdaq
- Market Cap
- OUT 2.4B
- RARE 2.6B
- IPO Year
- OUT N/A
- RARE 2014
- Fundamental
- Price
- OUT $18.62
- RARE $29.96
- Analyst Decision
- OUT Buy
- RARE Strong Buy
- Analyst Count
- OUT 7
- RARE 14
- Target Price
- OUT $19.44
- RARE $86.64
- AVG Volume (30 Days)
- OUT 1.7M
- RARE 1.4M
- Earning Date
- OUT 08-05-2025
- RARE 08-05-2025
- Dividend Yield
- OUT 6.42%
- RARE N/A
- EPS Growth
- OUT N/A
- RARE N/A
- EPS
- OUT 0.60
- RARE N/A
- Revenue
- OUT $1,796,000,000.00
- RARE $610,159,000.00
- Revenue This Year
- OUT N/A
- RARE $19.72
- Revenue Next Year
- OUT $2.79
- RARE $23.29
- P/E Ratio
- OUT $31.12
- RARE N/A
- Revenue Growth
- OUT N/A
- RARE 26.77
- 52 Week Low
- OUT $12.95
- RARE $25.81
- 52 Week High
- OUT $19.98
- RARE $60.37
- Technical
- Relative Strength Index (RSI)
- OUT 54.36
- RARE 53.11
- Support Level
- OUT $18.43
- RARE $29.04
- Resistance Level
- OUT $19.06
- RARE $30.61
- Average True Range (ATR)
- OUT 0.48
- RARE 0.80
- MACD
- OUT -0.02
- RARE 0.31
- Stochastic Oscillator
- OUT 57.75
- RARE 79.81
About OUT OUTFRONT Media Inc.
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.